ACS Biotech vision is to change the lives of millions of people suffering from osteoarticular pathologies through regenerative medicine and development of new cellular-based products.
Our solution for cartilage repair, aims to regenerate articular cartilage damage with our Cartilage gel with only one precise and mini-invasive surgery, practised by specialized orthopaedic surgeons. A few months later, patients could remain their mobility and sportive activities.
2 million knee injuries per year
Cartilage damage leads to OA:
pain, suffering, isolation, stress, stop sports
230 Million patients worldwide in 2022
Constant evolution with +40% by 2040